Suzhou Basecare Medical Corporation Limited
Suzhou Basecare Medical Corporation Limited (2170.HK) Stock Competitors & Peer Comparison
See (2170.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2170.HK | HK$2.00 | +3.09% | 547.1M | -1.96 | -HK$1.02 | N/A |
| 2252.HK | HK$26.44 | +4.75% | 28.1B | -49.93 | -HK$0.55 | N/A |
| 0853.HK | HK$9.17 | -3.27% | 17.6B | -13.07 | -HK$0.73 | N/A |
| 1858.HK | HK$13.07 | -0.31% | 8.2B | 28.81 | HK$0.48 | +2.05% |
| 1302.HK | HK$1.82 | +8.33% | 8B | 90.50 | HK$0.02 | N/A |
| 2190.HK | HK$23.70 | +1.98% | 7.7B | 28.05 | HK$0.86 | +0.45% |
| 1789.HK | HK$6.43 | +4.05% | 7.1B | 18.65 | HK$0.34 | +1.14% |
| 1763.HK | HK$20.00 | +0.40% | 6.5B | 13.50 | HK$1.51 | +2.09% |
| 6606.HK | HK$14.14 | +0.00% | 6.3B | 58.92 | HK$0.24 | N/A |
| 2172.HK | HK$10.81 | +2.76% | 6.3B | 30.47 | HK$0.36 | +1.46% |
Stock Comparison
2170.HK vs 2252.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2252.HK has a market cap of 28.1B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2252.HK trades at HK$26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2252.HK's P/E ratio is -49.93. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2252.HK's ROE of -0.52%. Regarding short-term risk, 2170.HK is less volatile compared to 2252.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 2252.HK's competition here
2170.HK vs 0853.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 0853.HK has a market cap of 17.6B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 0853.HK trades at HK$9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 0853.HK's P/E ratio is -13.07. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 0853.HK's ROE of -0.27%. Regarding short-term risk, 2170.HK is less volatile compared to 0853.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 0853.HK's competition here
2170.HK vs 1858.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 1858.HK has a market cap of 8.2B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 1858.HK trades at HK$13.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 1858.HK's P/E ratio is 28.81. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 1858.HK's ROE of +0.09%. Regarding short-term risk, 2170.HK is less volatile compared to 1858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 1858.HK's competition here
2170.HK vs 1302.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 1302.HK has a market cap of 8B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 1302.HK trades at HK$1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 1302.HK's P/E ratio is 90.50. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 1302.HK's ROE of +0.02%. Regarding short-term risk, 2170.HK is less volatile compared to 1302.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 1302.HK's competition here
2170.HK vs 2190.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2190.HK has a market cap of 7.7B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2190.HK trades at HK$23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2190.HK's P/E ratio is 28.05. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2190.HK's ROE of +0.08%. Regarding short-term risk, 2170.HK is less volatile compared to 2190.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 2190.HK's competition here
2170.HK vs 1789.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 1789.HK has a market cap of 7.1B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 1789.HK trades at HK$6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 1789.HK's P/E ratio is 18.65. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 1789.HK's ROE of +0.12%. Regarding short-term risk, 2170.HK is less volatile compared to 1789.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 1789.HK's competition here
2170.HK vs 1763.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 1763.HK has a market cap of 6.5B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 1763.HK trades at HK$20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 1763.HK's P/E ratio is 13.50. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 1763.HK's ROE of +0.08%. Regarding short-term risk, 2170.HK is more volatile compared to 1763.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2170.HK.Check 1763.HK's competition here
2170.HK vs 6606.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 6606.HK has a market cap of 6.3B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 6606.HK trades at HK$14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 6606.HK's P/E ratio is 58.92. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 6606.HK's ROE of -0.04%. Regarding short-term risk, 2170.HK is less volatile compared to 6606.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 6606.HK's competition here
2170.HK vs 2172.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2172.HK has a market cap of 6.3B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2172.HK trades at HK$10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2172.HK's P/E ratio is 30.47. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2172.HK's ROE of +0.10%. Regarding short-term risk, 2170.HK is less volatile compared to 2172.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 2172.HK's competition here
2170.HK vs 9996.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 9996.HK has a market cap of 4.1B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 9996.HK trades at HK$6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 9996.HK's P/E ratio is -17.60. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 9996.HK's ROE of -0.11%. Regarding short-term risk, 2170.HK is less volatile compared to 9996.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 9996.HK's competition here
2170.HK vs 6669.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 6669.HK has a market cap of 3.9B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 6669.HK trades at HK$13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 6669.HK's P/E ratio is 29.55. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 6669.HK's ROE of +0.07%. Regarding short-term risk, 2170.HK is less volatile compared to 6669.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 6669.HK's competition here
2170.HK vs 2235.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2235.HK has a market cap of 3B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2235.HK trades at HK$7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2235.HK's P/E ratio is -105.43. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2235.HK's ROE of -0.01%. Regarding short-term risk, 2170.HK is more volatile compared to 2235.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2170.HK.Check 2235.HK's competition here
2170.HK vs 6609.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 6609.HK has a market cap of 1.8B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 6609.HK trades at HK$48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 6609.HK's P/E ratio is 19.30. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 6609.HK's ROE of +0.04%. Regarding short-term risk, 2170.HK is less volatile compared to 6609.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 6609.HK's competition here
2170.HK vs 1696.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 1696.HK has a market cap of 1.6B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 1696.HK trades at HK$3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 1696.HK's P/E ratio is 10.50. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 1696.HK's ROE of +0.04%. Regarding short-term risk, 2170.HK is more volatile compared to 1696.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2170.HK.Check 1696.HK's competition here
2170.HK vs 2160.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2160.HK has a market cap of 1.4B. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2160.HK trades at HK$2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2160.HK's P/E ratio is 146.50. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2160.HK's ROE of +0.00%. Regarding short-term risk, 2170.HK is less volatile compared to 2160.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 2160.HK's competition here
2170.HK vs 2500.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2500.HK has a market cap of 954.6M. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2500.HK trades at HK$2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2500.HK's P/E ratio is -1.31. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2500.HK's ROE of -0.30%. Regarding short-term risk, 2170.HK is less volatile compared to 2500.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 2500.HK's competition here
2170.HK vs 2407.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2407.HK has a market cap of 782.3M. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2407.HK trades at HK$5.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2407.HK's P/E ratio is 7.05. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2407.HK's ROE of +0.06%. Regarding short-term risk, 2170.HK is less volatile compared to 2407.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 2407.HK's competition here
2170.HK vs 2216.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2216.HK has a market cap of 773.9M. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2216.HK trades at HK$1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2216.HK's P/E ratio is -6.12. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2216.HK's ROE of -0.09%. Regarding short-term risk, 2170.HK is less volatile compared to 2216.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 2216.HK's competition here
2170.HK vs 1612.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 1612.HK has a market cap of 610.3M. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 1612.HK trades at HK$0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 1612.HK's P/E ratio is 5.87. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 1612.HK's ROE of +0.16%. Regarding short-term risk, 2170.HK is less volatile compared to 1612.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 1612.HK's competition here
2170.HK vs 6118.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 6118.HK has a market cap of 410.1M. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 6118.HK trades at HK$0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 6118.HK's P/E ratio is 10.00. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 6118.HK's ROE of +0.04%. Regarding short-term risk, 2170.HK is less volatile compared to 6118.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2170.HK.Check 6118.HK's competition here
2170.HK vs 2297.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2297.HK has a market cap of 385.4M. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2297.HK trades at HK$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2297.HK's P/E ratio is -2.75. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2297.HK's ROE of -0.26%. Regarding short-term risk, 2170.HK is more volatile compared to 2297.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2170.HK.Check 2297.HK's competition here
2170.HK vs 2393.HK Comparison April 2026
2170.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2170.HK stands at 547.1M. In comparison, 2393.HK has a market cap of 235.5M. Regarding current trading prices, 2170.HK is priced at HK$2.00, while 2393.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2170.HK currently has a P/E ratio of -1.96, whereas 2393.HK's P/E ratio is -1.26. In terms of profitability, 2170.HK's ROE is -0.22%, compared to 2393.HK's ROE of -0.35%. Regarding short-term risk, 2170.HK is more volatile compared to 2393.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2170.HK.Check 2393.HK's competition here